JP2557111B2 - Method for producing high-concentration magnesium solution, magnesium solution obtained thereby and use thereof - Google Patents

Method for producing high-concentration magnesium solution, magnesium solution obtained thereby and use thereof

Info

Publication number
JP2557111B2
JP2557111B2 JP1304889A JP30488989A JP2557111B2 JP 2557111 B2 JP2557111 B2 JP 2557111B2 JP 1304889 A JP1304889 A JP 1304889A JP 30488989 A JP30488989 A JP 30488989A JP 2557111 B2 JP2557111 B2 JP 2557111B2
Authority
JP
Japan
Prior art keywords
magnesium
magnesium solution
concentration
solution obtained
solution
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
JP1304889A
Other languages
Japanese (ja)
Other versions
JPH03168067A (en
Inventor
蘭子 井上
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Fujix Corp
Original Assignee
Fujix Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Fujix Corp filed Critical Fujix Corp
Priority to JP1304889A priority Critical patent/JP2557111B2/en
Publication of JPH03168067A publication Critical patent/JPH03168067A/en
Application granted granted Critical
Publication of JP2557111B2 publication Critical patent/JP2557111B2/en
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Landscapes

  • Coloring Foods And Improving Nutritive Qualities (AREA)
  • Jellies, Jams, And Syrups (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)

Description

【発明の詳細な説明】 (産業上の利用分野) 本発明は、難溶性のマグネシウムまたはマグネシウム
化合物を高濃度で含有することができる均質な醗酵乳酸
溶液、ならびにその用途に関する。
TECHNICAL FIELD The present invention relates to a homogeneous fermented lactic acid solution which can contain a sparingly soluble magnesium or magnesium compound in a high concentration, and its use.

(従来の技術及びその問題点) マグネシウムは下記のような特徴を有するので、緩下
剤やその他の医薬品としても、又、栄養補給にも昔から
使用されてきた。
(Prior art and its problems) Since magnesium has the following characteristics, it has been used for a long time as a laxative, other medicinal product, and nutritional supplement.

繊維と同様に保水効果がある。 It has a water retention effect similar to fiber.

大腸の水分吸収を抑えて便を軟かくしスムーズに排
泄する。
It suppresses water absorption in the large intestine, softens stool and excretes smoothly.

飲みすぎても腹痛がおこらず副作用なし。 If you drink too much, there will be no abdominal pain and no side effects.

腔中の酸を中和し、歯を丈夫にし舌や口中のあれを
治す。
It neutralizes the acid in the cavity, strengthens the teeth and heals the tongue and mouth.

胃酸を適正に調和し、胃壁の小さなタダレを治す。 It properly balances the acidity of the stomach and cures small lumps on the stomach wall.

小腸内壁の炎症を治し、栄養の吸収を良くする。 It cures inflammation of the lining of the small intestine and improves nutrient absorption.

腸の働きを活発にし、腸壁にこびりついた宿便をと
る。
Activate the intestines and take the bowel movements that stick to the intestinal wall.

発ガン物質である一酸化炭素を消す。 Extinguishes carbon monoxide, a carcinogen.

栄養素としてのマグネシウムの働き。 The function of magnesium as a nutrient.

以上の如く、人体に於て上記のような特性を備え、こ
とに便秘薬としては副作用も痛みも伴なわない最も理想
的な素材であるにもかかわらず、広く大衆に使用されて
いないのは大量に飲まなければ効果が得られないうえ、
非常に現状の製品では飲みにくいためであるということ
がわかった。
As described above, it has the above-mentioned properties in the human body, and is the most ideal material as a constipation drug with neither side effects nor pain, but it is not widely used by the general public. If you don't drink too much, you won't get the effect,
It turns out that it is difficult to drink with the current products.

そこで、マグネシウムまたはマグネシウム化合物を高
濃度で含有する液体とし、且つ、飲み易くするにはどう
したらようかという店に着目して研究を重ねてきたが、
その研究を進める過程で最も大きな障害となったのは大
量に飲まなければならないのに(便秘の効果を得るため
には約2,000mgを1回に飲む必要がある)マグネシウム
またはマグネシウム化合物の溶解度の低さという店であ
る。
Therefore, we have been conducting research by focusing on a store that makes it a liquid containing magnesium or a magnesium compound at a high concentration, and how to make it easy to drink.
The biggest obstacle in the course of the study was the need to drink large amounts (about 2,000 mg per dose to get the effect of constipation) of magnesium or magnesium compound solubility. It's a low store.

従来下記に示す如く、クエン酸、リンゴ酸、酢酸、塩
酸、乳酸によりマグネシウムまたはマグネシウム化合物
の溶解を試みたがマグネシウムまたはマグネシウム化合
物が高濃度で含有し、かつ、飲み易い味の液体及び加工
食品は得られなかった。
Conventionally, as shown below, citric acid, malic acid, acetic acid, hydrochloric acid, tried to dissolve magnesium or magnesium compound with lactic acid, but magnesium or magnesium compound is contained at a high concentration, and the liquid and processed food with easy taste are I couldn't get it.

又従来、水酸化マグネシウムを含有した乳液状の制酸
緩下剤は発売され公知である(製造元:株式会社 三保
製薬研究所 商品名スイマグ)。
Further, conventionally, an emulsion-type antacid laxative containing magnesium hydroxide has been released and is publicly known (manufacturer: Miho Pharmaceutical Laboratory Co., Ltd., trade name Suimag).

しかし乍ら、2,000mg飲まないと排便効果が得られ
ず、量が多いので錠剤でも水溶液でも飲み難く、酸に可
溶でも酸が強度であるため非常に飲用しにくい。
However, the defecation effect cannot be obtained unless 2,000 mg is taken, and it is difficult to take tablets or an aqueous solution because of the large amount, and it is very difficult to drink because it is soluble in acid and the acid is strong.

(発明の目的) 本発明は難溶性で、かつ、まずいマグネシウムまたは
マグネシウム化合物を、極めて飲み易い状態又は食べや
すい状態で提供することを目的とする。
(Object of the Invention) An object of the present invention is to provide a poorly soluble and poor magnesium or magnesium compound in an extremely easy-to-drink state or an easy-to-eat state.

(問題点を解決するための手段) 本発明は上記目的を達成するためになされたもので、
マグネシウム化合物を水溶液とし、醗酸法により製造し
た乳酸溶液を加えた後、40℃以下の温度で溶解すること
により、高濃度のマグネシウムまたはマグネシウム化合
物を含有するマグネシウム液剤または該マグネシウム液
剤を添加した飲料及び加工食品を得ることを見い出した
ものである。
(Means for Solving Problems) The present invention has been made to achieve the above object,
Magnesium compound as an aqueous solution, after adding a lactic acid solution produced by the lactic acid method, by dissolving at a temperature of 40 ℃ or less, magnesium solution containing a high concentration of magnesium or magnesium compound or a beverage containing the magnesium solution And to obtain processed foods.

(発明の好適態様) 醗酵法により製造した乳酸 醗酵乳酸とはC3H6O3で表わされるもので、デンプンな
どの糖類を原料として乳酸菌をはたらかせることによっ
て醗酵させたもので、式 で表わされる光学活性型L(+)乳酸が好適に使用され
る。
The lactic acid fermentation lactic acid produced by fermentation (the preferred embodiment of the invention) those represented by C 3 H 6 O 3, which was fermented by exert a lactic acid bacteria of sugars such as starch as a raw material, wherein The optically active L (+) lactic acid represented by is preferably used.

醗酵法により製造した乳酸は、未反応のでんぷん、ぶ
どう糖等を含有するため、刺激のないまろやかな味を有
しており、食品本来の味を損ねることがない。
Lactic acid produced by the fermentation method contains unreacted starch, glucose, etc., and thus has a mild taste without irritation and does not impair the original taste of food.

本発明に用いるマグネシウムまたはマグネシウム化合
物は天然に存在するもの(例えば、海水中のニガリ等)
及び工業用に合成されたもの何れでもよい。
The magnesium or magnesium compound used in the present invention is a naturally occurring one (for example, bittern in seawater).
Also, any of those synthesized for industrial use may be used.

ニガリについては鉄、カルシウム、硫黄分を微量含む
が溶解可能である。
Bittern contains trace amounts of iron, calcium and sulfur, but can be dissolved.

(実施例) 実施例1. マグネシウム溶液製法の実施例 水85ccに対してマグネシウムの粉未(平均粒径200メ
ッシュ)2.0grを加え撹拌しマグネシウムの水溶液を得
た。
(Example) Example 1. Example of magnesium solution manufacturing method To 85 cc of water, 2.0 g of magnesium powder (average particle size: 200 mesh) was added and stirred to obtain an aqueous solution of magnesium.

次に90%濃度の醗酵法により製造した乳酸の水溶液15
ccを前記マグネシウムの水溶液と混合した。これを30℃
の撹拌槽を有する恒温槽で10分間撹拌を行った後、常温
で静置した所、10週間後に於てもマグネシウムの沈澱は
全く認められず、しかも厚味のあるたおやかな酸味を有
する水溶性緩下剤が得られた。
Next, a 90% aqueous solution of lactic acid produced by fermentation 15
cc was mixed with the aqueous magnesium solution. 30 ° C
After stirring for 10 minutes in a constant temperature bath with a stirring tank, the mixture was allowed to stand at room temperature, no precipitation of magnesium was observed even after 10 weeks, and it was water-soluble with a thick and mild acidity. A laxative was obtained.

実施例2. 実施例1によって得られたマグネシウム溶液100ccに
水飴200gr、グラニュー糖200grを混合し、75±5℃の温
度でブリックスが75乃至76になるまで加熱した後、加熱
温度を60℃に下げ、そのまゝ静置した(原料1)。
Example 2 100 ml of the magnesium solution obtained in Example 1 was mixed with 200 ml of starch syrup and 200 gr of granulated sugar, and the mixture was heated at a temperature of 75 ± 5 ° C. until the brix became 75 to 76, and then the heating temperature was raised to 60 ° C. Lowered and let it stand still (raw material 1).

別の容器に寒天15gr、水500ccを混ぜ、90℃で加熱を
行い、その後、寒天の泡を除いてオリゴ糖500grを加
え、75±5℃でブリックスが75〜76になる迄、加熱を続
けた(原料2)。
Mix agar (15gr) and water (500cc) in another container, heat at 90 ℃, remove the agar foam, add oligosaccharide (500gr), and continue heating at 75 ± 5 ℃ until the brix becomes 75-76. (Raw material 2).

次に原料1と原料2をよく混ぜ合わせ約65℃の温度で
型に流し込み、ゼリー状に固化したら取り出し規定の寸
法にカットし、約40℃の乾燥機で最終ブリックス80にな
る迄、約20時間乾燥した。
Next, mix raw material 1 and raw material 2 well, pour into a mold at a temperature of about 65 ° C, take out after solidifying into a jelly form, cut into specified dimensions, and dry at about 40 ° C until the final brix 80 reaches about 20. Dried for hours.

こうして得られたゼリーは1.5cm×3cm×1.5cmの寸法
で重量は約3grである。その一片につき約100mgのマグネ
シウムを含有する高濃度のマグネシウム入り加工食品が
得られた。
The jelly thus obtained measures 1.5 cm × 3 cm × 1.5 cm and weighs about 3 gr. A processed food with a high concentration of magnesium containing about 100 mg of magnesium per piece was obtained.

Claims (4)

(57)【特許請求の範囲】(57) [Claims] 【請求項1】マグネシウムまたはマグネシウム化合物を
あらかじめ水溶液としたものに、醗酵法により製造した
乳酸溶液を加えた後、40℃以下の温度で溶解することを
特徴とする高濃度のマグネシウム溶液の製造方法。
1. A method for producing a high-concentration magnesium solution, which comprises adding a lactic acid solution produced by a fermentation method to a solution of magnesium or a magnesium compound in advance and then dissolving it at a temperature of 40 ° C. or lower. .
【請求項2】請求項1記載の方法によって得られた高濃
度のマグネシウム溶液。
2. A high-concentration magnesium solution obtained by the method according to claim 1.
【請求項3】請求項1記載の方法によって得られた高濃
度マグネシウム溶液からなる液状緩下剤。
3. A liquid laxative comprising a high-concentration magnesium solution obtained by the method of claim 1.
【請求項4】請求項1記載の方法によって得られた高濃
度のマグネシウム溶液を添加した加工食品。
4. A processed food to which a high-concentration magnesium solution obtained by the method according to claim 1 is added.
JP1304889A 1989-11-27 1989-11-27 Method for producing high-concentration magnesium solution, magnesium solution obtained thereby and use thereof Expired - Lifetime JP2557111B2 (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
JP1304889A JP2557111B2 (en) 1989-11-27 1989-11-27 Method for producing high-concentration magnesium solution, magnesium solution obtained thereby and use thereof

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
JP1304889A JP2557111B2 (en) 1989-11-27 1989-11-27 Method for producing high-concentration magnesium solution, magnesium solution obtained thereby and use thereof

Publications (2)

Publication Number Publication Date
JPH03168067A JPH03168067A (en) 1991-07-19
JP2557111B2 true JP2557111B2 (en) 1996-11-27

Family

ID=17938503

Family Applications (1)

Application Number Title Priority Date Filing Date
JP1304889A Expired - Lifetime JP2557111B2 (en) 1989-11-27 1989-11-27 Method for producing high-concentration magnesium solution, magnesium solution obtained thereby and use thereof

Country Status (1)

Country Link
JP (1) JP2557111B2 (en)

Cited By (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US8999313B2 (en) 2012-09-11 2015-04-07 Norgine Bv Compositions
US9592252B2 (en) 2011-03-11 2017-03-14 Norgine Bv Colonoscopy—preparation
US10624879B2 (en) 2014-03-19 2020-04-21 Ferring International Center S.A. Liquid pharmaceutical composition
US11612592B2 (en) 2015-08-17 2023-03-28 Ferring B.V. Liquid formulations containing picosulfate and magnesium citrate

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPH07143863A (en) * 1993-11-24 1995-06-06 Maguoole Sci Kk Method for producing magnesium-reinforced food

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS6055496A (en) * 1983-09-07 1985-03-30 株式会社日立製作所 Job direction/operation recorder
GB8718969D0 (en) * 1987-08-11 1987-09-16 Pentlands Scotch Whisky Resear Foodstuffs compositions

Cited By (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US9592252B2 (en) 2011-03-11 2017-03-14 Norgine Bv Colonoscopy—preparation
US11529368B2 (en) 2011-03-11 2022-12-20 Norgine Bv Colonoscopy—preparation
US8999313B2 (en) 2012-09-11 2015-04-07 Norgine Bv Compositions
US9326969B2 (en) 2012-09-11 2016-05-03 Norgine Bv Compositions
US9707297B2 (en) 2012-09-11 2017-07-18 Norgine Bv Compositions
US10016504B2 (en) 2012-09-11 2018-07-10 Norgine Bv Compositions
US10624879B2 (en) 2014-03-19 2020-04-21 Ferring International Center S.A. Liquid pharmaceutical composition
US11191753B2 (en) 2014-03-19 2021-12-07 Ferring International Center Sa. Liquid pharmaceutical composition
US11612592B2 (en) 2015-08-17 2023-03-28 Ferring B.V. Liquid formulations containing picosulfate and magnesium citrate

Also Published As

Publication number Publication date
JPH03168067A (en) 1991-07-19

Similar Documents

Publication Publication Date Title
JP2643669B2 (en) Algin-containing foods
JP4702745B2 (en) Mineral absorption promoter and its use
JP4352354B2 (en) Solid instant jelly mix
DE60307249T2 (en) IRON-DEXTRINE CONNECTION FOR TREATING ANIMALS THROUGH IRON DEFICIENCY
JP5214978B2 (en) Composition having blood pressure lowering action and / or elevation suppressing action and food and drink containing the same
CA2229658A1 (en) Combination osmotic and bulk forming laxatives
JP2557111B2 (en) Method for producing high-concentration magnesium solution, magnesium solution obtained thereby and use thereof
JP2000325041A (en) Swallowing assisting food
NL8802383A (en) MAGNESIUM CONTAINING ADDITIVES FOR FOODSTUFFS, FEED AND MEDICINAL PRODUCTS.
EP1834528B1 (en) Process for production of jellylike drinks
JP2021159063A (en) Konjak functional food and method for producing the same
JP3666094B2 (en) Calcium liquid, calcium beverage and method for producing the same
JP2003192573A (en) Oral gel preparation
JP2009100667A (en) Method for producing gel-like composition
CN108185251B (en) Podocarpus macrophyllus cloudy juice beverage and preparation method thereof
JP3131385B2 (en) Composition containing easily absorbable calcium and method for producing the same
JP2564648B2 (en) Liquid food additive containing high concentration of ionized calcium, method for producing the same, and processed food to which the food additive is added
WO2017198477A1 (en) Edible semi-solid composition for use in patients undergoing endoscopy including colonoscopy
JPH09121811A (en) Easily absorbable calcium composition
CN103478732B (en) A kind of matrix sustained-release vitamin functional food and preparation method thereof
JP3507722B2 (en) Method for producing calcium-containing transparent soft drink
CN108925806A (en) It is a kind of to help the sea cucumber gel drink swallowed and its preparation process and purposes
JP6206420B2 (en) Method for producing gel composition containing ferric citrate at high concentration
JPH0352691A (en) Acid-containing water
RU2694970C1 (en) Method for production of jelly marmalade of functional purpose

Legal Events

Date Code Title Description
R250 Receipt of annual fees

Free format text: JAPANESE INTERMEDIATE CODE: R250

FPAY Renewal fee payment (event date is renewal date of database)

Free format text: PAYMENT UNTIL: 20100905

Year of fee payment: 14

EXPY Cancellation because of completion of term
FPAY Renewal fee payment (event date is renewal date of database)

Free format text: PAYMENT UNTIL: 20100905

Year of fee payment: 14